Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma (clinicaltrials.gov) - Apr 18, 2025 - P2 | N=40 | Terminated | Sponsor: Alaunos Therapeutics | Completed ➔ Terminated; Sponsor Decision
Trial termination • Brain Cancer • CNS Tumor • Glioblastoma • Oncology • Solid Tumor
|